KEY FINDINGS The global pulmonary drug delivery market is anticipated to register a CAGR of 5.06%, during the forecast years of 2019 to 2028. The key drivers, such as advancements in technology, the surging prevalence of respiratory diseases, and the rising geriatric population, are attributed to market growth.
MARKET INSIGHTS With its recent introduction into the pharmaceutical field, pulmonary drug delivery systems are used to treat both local as well as systemic types of lung diseases.They are characterized by their ability to directly deliver medication to the designated location in the body or other distant sites through the bloodstream.
Moreover, different forms of drug delivery systems, including inhalers and nebulizers, were introduced as alternative treatments for diverse lung conditions. Technology plays a crucial role in daily lives, and is consistently evolving.As a result, the rising demand for innovative products, incorporated with changing lifestyles, the need for convenience, and better facilities, leads to technological developments.
Similarly, the market for pulmonary drug delivery is fuelled by rising advancements in technology, and is projected to generate potential growth opportunities. The limitations of conventional treatments, such as low efficacy and delayed onset of action, are also predicted to encourage the development of innovative and superior targeted drug delivery systems.
REGIONAL INSIGHTS The global pulmonary drug delivery market growth is geographically analyzed through the Asia Pacific, Europe, North America, and the rest of the world.The Asia Pacific is projected to be the fastest-growing region, owing to the high incidence of chronic obstructive pulmonary disease (COPD), indicating significant socioeconomic problems.
The rising number of patients with allergic rhinitis and asthma also contributes to the region’s market growth.
COMPETITIVE INSIGHTS The market is competitive, with major players engaged in constant product developments, in addition to partnership agreements to ease market penetration.Moreover, the growing number of dealers and distributors is predicted to intensify the industry rivalry, in the upcoming years.
Leading companies operating in the market include, Boehringer Ingelheim GmbH, 3M Company, GlaxoSmithKline PLC, Koninklijke Philips NV, AstraZeneca PLC, etc.
Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Companies mentioned 1. 3M COMPANY 2. ACTELION PHARMACEUTICALS LTD 3. AEROGEN 4. AGILENT TECHNOLOGIES INC 5. ASTRAZENECA PLC 6. BOEHRINGER INGELHEIM GMBH 7. CLEMENT CLARKE INTERNATIONAL 8. GF HEALTH PRODUCTS INC 9. GLAXOSMITHKLINE PLC 10. KONINKLIJKE PHILIPS NV 11. MERCK & CO INC 12. NOVARTIS AG 13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED 14. VECTURA GROUP PLC
Our reports have been used by over 10K customers, including:
Report Scope This report analyzes the market trends of microneedles with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through the forecast period of 2021 to 2026). Regulatory scenarios, drivers, restraints and opportunities will be covered, as well as market shares for leading...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca. The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth...
United States Connected Drug Delivery Devices Market, By Product Type (Connected Sensors v/s Integrated Connected Devices), By Technology (Bluetooth, Near Field Communication, Others), By Application (Asthma & COPD, Diabetes, Others), By End User (Healthcare Providers v/s Homecare), By Region, Competition Forecast & Opportunities,...
The global isosorbide market exhibited moderate growth during 2015-2020. Also known as D-Isosorbide dinitrate, isosorbide (C6H10O4) is a bio-product obtained from starch. The derivatives of isosorbide, namely isosorbide dinitrate and isosorbide mononitrate, find extensive applications across various end use industries...
693 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Jul 2021
Drug Delivery Systems (DDS) are the advanced formulations or technologies that modulate the release profile of therapeutic or prophylactic agents, their absorption, distribution and elimination characteristics to achieve the desired therapeutic effect and enhance the safety profile, patient convenience and compliance to medications...
Forecasts by Technology (Oral Drug Delivery Therapy, Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery, Ocular Drug Delivery, Others), by Indication (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Others), by Distribution...
Microspheres: Market Size From $5.62 billion in 2020, the global Microspheres market is projected to reach $12.96 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 11.0% from 2020 - 2028 timeframe. Some of the prominent trends that the market is witnessing include, emerging economies...
Drug Delivery Technologies: Market Size From $1,451.50 billion in 2020, the global Drug Delivery Technologies market is projected to reach $3,203.09 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 10.4% from 2020 - 2028 timeframe. Some of the prominent trends that the market...
This report aims to provide a comprehensive study of the global market for transdermal drug delivery technologies/systems. It provides a detailed description of the different types of transdermal drug delivery systems (passive and active) and the current and historical market revenues.
539 pages •
By Roots Analysis Private Ltd.
• Jun 2021
Around 90% of the drug candidates in the current development pipeline and close to 40% of marketed pharmacological products, have been associated with concerns related to solubility and / or permeability. , In this context, considering modern regulatory standards, a large number of potential therapeutic leads...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.